Polyglutamine Atrophin provokes neurodegeneration in Drosophila by repressing fat

Francesco Napoletano1, Simona Occhi, Piera Calamita

  • 1Dulbecco Telethon Institute and Division of Neuroscience, DIBIT-San Raffaele Scientific Institute, Milan, Italy.

The EMBO Journal
|February 1, 2011
PubMed

Insights

The fat gene protects against neurodegeneration in polyglutamine (polyQ) diseases by regulating the Hippo pathway. This pathway alters autophagic flux, offering a novel therapeutic target for neurodegenerative disorders.

Area of Science:

  • Neurobiology
  • Genetics
  • Molecular Biology

Background:

  • Neurodegeneration in polyglutamine (polyQ) diseases involves significant transcriptional changes.
  • Both general polyQ toxicity and specific mutant protein effects contribute to these pathologies.

Purpose of the Study:

  • To investigate the role of the fat tumor suppressor gene in polyQ-induced neurodegeneration.
  • To identify early transcriptional alterations in a Drosophila model of Dentatorubral-pallidoluysian Atrophy (DRPLA).

Main Methods:

  • Monitoring transcriptional alterations in a Drosophila model of DRPLA.
  • Investigating the function of the fat gene and Hippo kinase cascade in neurodegeneration.

Main Results:

  • PolyQ Atrophins downregulate the fat gene in Drosophila models.
  • Fat/Hippo signaling protects against Atrophin-induced neurodegeneration.
  • Fat/Hippo pathway alters autophagic flux in photoreceptor neurons, impacting cell homeostasis.

Conclusions:

  • The fat tumor suppressor gene plays a critical role in mediating neurodegeneration caused by the polyQ protein Atrophin.
  • The Fat/Hippo pathway exhibits unexpected neuroprotective functions in polyQ diseases by modulating autophagic flux, not overgrowth.
  • These findings offer new insights into the mechanisms of polyQ diseases and suggest potential therapeutic strategies targeting the Fat/Hippo pathway.

Related Concept Videos